Hans‐Dieter Orzechowski

4.0k total citations
47 papers, 1.9k citations indexed

About

Hans‐Dieter Orzechowski is a scholar working on Physiology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Hans‐Dieter Orzechowski has authored 47 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 13 papers in Molecular Biology and 12 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Hans‐Dieter Orzechowski's work include Nitric Oxide and Endothelin Effects (15 papers), Renin-Angiotensin System Studies (7 papers) and Autoimmune Bullous Skin Diseases (6 papers). Hans‐Dieter Orzechowski is often cited by papers focused on Nitric Oxide and Endothelin Effects (15 papers), Renin-Angiotensin System Studies (7 papers) and Autoimmune Bullous Skin Diseases (6 papers). Hans‐Dieter Orzechowski collaborates with scholars based in Germany, United States and France. Hans‐Dieter Orzechowski's co-authors include Martin Paul, Roland Wensel, Gert Hoeffken, Heinz‐Peter Schultheiss, Ralf Ewert, Michael Halank, Hermann Herbst, G. Pellegrini, P. Neuhaus and Stefano Milani and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Neuroscience.

In The Last Decade

Hans‐Dieter Orzechowski

47 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans‐Dieter Orzechowski Germany 23 500 436 433 340 331 47 1.9k
Noritaka Kawada Japan 21 641 1.3× 234 0.5× 682 1.6× 210 0.6× 264 0.8× 40 2.1k
Juan Rodríguez‐Vita Spain 23 623 1.2× 214 0.5× 1.4k 3.1× 169 0.5× 341 1.0× 36 2.9k
Christoph Otto Germany 28 124 0.2× 625 1.4× 869 2.0× 477 1.4× 250 0.8× 133 2.8k
Dechun Li China 19 504 1.0× 881 2.0× 557 1.3× 140 0.4× 474 1.4× 39 2.0k
Sandra Merscher United States 26 141 0.3× 238 0.5× 1.2k 2.7× 423 1.2× 302 0.9× 56 2.9k
Daniela Rottoli Italy 32 523 1.0× 420 1.0× 1.5k 3.6× 357 1.1× 321 1.0× 47 4.1k
Daniela Macconi Italy 26 344 0.7× 276 0.6× 638 1.5× 118 0.3× 202 0.6× 47 2.2k
Anna Franca Milia Italy 25 345 0.7× 192 0.4× 624 1.4× 438 1.3× 107 0.3× 53 1.9k
Babu J. Padanilam United States 32 216 0.4× 196 0.4× 1.4k 3.1× 437 1.3× 205 0.6× 68 2.8k
Andrea Hartner Germany 31 662 1.3× 416 1.0× 1.1k 2.5× 87 0.3× 332 1.0× 111 3.3k

Countries citing papers authored by Hans‐Dieter Orzechowski

Since Specialization
Citations

This map shows the geographic impact of Hans‐Dieter Orzechowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Dieter Orzechowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Dieter Orzechowski more than expected).

Fields of papers citing papers by Hans‐Dieter Orzechowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans‐Dieter Orzechowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Dieter Orzechowski. The network helps show where Hans‐Dieter Orzechowski may publish in the future.

Co-authorship network of co-authors of Hans‐Dieter Orzechowski

This figure shows the co-authorship network connecting the top 25 collaborators of Hans‐Dieter Orzechowski. A scholar is included among the top collaborators of Hans‐Dieter Orzechowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans‐Dieter Orzechowski. Hans‐Dieter Orzechowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schultz, Olaf, et al.. (2024). Real-world experience with filgotinib for rheumatoid arthritis in Germany. Zeitschrift für Rheumatologie. 84(1). 39–47. 1 indexed citations
2.
Fiehn, Christoph, C. Kneitz, Francesco De Leonardis, et al.. (2023). POS0851 REAL-WORLD EXPERIENCE WITH FILGOTINIB (FIL) FOR RHEUMATOID ARTHRITIS (RA) IN GERMANY: A RETROSPECTIVE CHART REVIEW. Annals of the Rheumatic Diseases. 82. 727–728. 1 indexed citations
3.
Fiehn, Christoph, et al.. (2023). Real-world treatment persistence in patients with rheumatoid arthritis initiating DMARDs in Germany—a health insurance claims data analysis. Zeitschrift für Rheumatologie. 82(9). 739–753. 1 indexed citations
4.
Balsa, Alejandro, S Wassenberg, Anne Tournadre, et al.. (2022). POS0518 EFFECT OF FILGOTINIB (FIL) ON BODY WEIGHT (BW) AND BODY MASS INDEX (BMI) AND EFFECT OF BASELINE BMI ON THE EFFICACY AND SAFETY OF FIL IN RHEUMATOID ARTHRITIS (RA). Annals of the Rheumatic Diseases. 81. 516–517. 2 indexed citations
5.
Bokemeyer, Bernd, et al.. (2020). Indicators of active disease and steroid dependency in patients with inflammatory bowel diseases not treated with biologics in a German real-world-setting. International Journal of Colorectal Disease. 35(8). 1587–1598. 8 indexed citations
6.
Schmidt, Enno, Michael Sticherling, Miklós Sárdy, et al.. (2020). S2k‐Leitlinie zur Therapie des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoids: 2019 Update. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 18(5). 516–527. 16 indexed citations
7.
Wilke, Thomas, et al.. (2019). Persistence with Biologic Treatment in Patients with Inflammatory Bowel Disease: A German Claims Data Analysis. Digestion. 102(2). 216–226. 18 indexed citations
8.
9.
Cissé, Moustapha, Eric Duplan, Marie‐Victoire Guillot‐Sestier, et al.. (2011). The Extracellular Regulated Kinase-1 (ERK1) Controls Regulated α-Secretase-mediated Processing, Promoter Transactivation, and mRNA Levels of the Cellular Prion Protein. Journal of Biological Chemistry. 286(33). 29192–29206. 22 indexed citations
10.
Gschwend, Simone, Angela Schulz, Roland Vetter, et al.. (2009). Short-term treatment with a beta-blocker with vasodilative capacities improves intrarenal endothelial function in experimental renal failure. Life Sciences. 85(11-12). 431–437. 13 indexed citations
11.
12.
Funke‐Kaiser, Heiko, Alexander Thomas, Juliane Bremer, et al.. (2003). Regulation of the major isoform of human endothelin-converting enzyme-1 by a strong housekeeping promoter modulated by polymorphic microsatellites. Journal of Hypertension. 21(11). 2111–2124. 24 indexed citations
13.
Kaehler, Jan, B. Sill, Ralf Koester, et al.. (2002). Endothelin-1 mRNA and protein in vascular wall cells is increased by reactive oxygen species. Clinical Science. 103(s2002). 176S–178S. 38 indexed citations
14.
Orzechowski, Hans‐Dieter, Andreas Zimmermann, Heiko Funke‐Kaiser, et al.. (2001). Transcriptional Mechanism of Protein Kinase C-Induced Isoform-Specific Expression of the Gene for Endothelin-Converting Enzyme-1in Human Endothelial Cells. Molecular Pharmacology. 60(6). 1332–1342. 21 indexed citations
15.
Köhler, Ralf, Susanne Brakemeier, Hans‐Dieter Orzechowski, et al.. (2001). Impaired Hyperpolarization in Regenerated Endothelium After Balloon Catheter Injury. Circulation Research. 89(2). 174–179. 58 indexed citations
16.
Kähler, Jan, Hans‐Dieter Orzechowski, Clemens Mittmann, et al.. (2000). Oxidative Stress Increases Synthesis of Big Endothelin-1 by Activation of the Endothelin-1 Promoter. Journal of Molecular and Cellular Cardiology. 32(8). 1429–1437. 126 indexed citations
17.
Stallmach, Andreas, et al.. (1999). 32/67-Kd Laminin Receptor Expression in Human Colonic Neoplasia: Elevated Transcript Levels Correlate With The Degree of Epithelial Dysplasia. The American Journal of Gastroenterology. 94(11). 3341–3347. 10 indexed citations
18.
Orzechowski, Hans‐Dieter, et al.. (1998). Endothelial Expression of Endothelin-Converting Enzyme-1β mRNA Is Regulated by the Transcription Factor Ets-1. Journal of Cardiovascular Pharmacology. 31. S55–S57. 14 indexed citations
19.
Orzechowski, Hans‐Dieter, et al.. (1995). Expression of CD44v6 is associated with cellular dysplasia in colorectal epithelial cells. European Journal of Cancer. 31(12). 2073–2079. 30 indexed citations
20.
Stallmach, Andreas, B Lampe, Hans‐Dieter Orzechowski, Harald Matthes, & Ernst-Otto Riecken. (1994). Increased fibronectin-receptor expression in colon carcinoma-derived HT 29 cells decreases tumorigenicity in nude mice. Gastroenterology. 106(1). 19–27. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noritaka Kawada Breakdown of academic impact, for papers by Juan Rodríguez‐Vita Breakdown of academic impact, for papers by Christoph Otto Breakdown of academic impact, for papers by Dechun Li Breakdown of academic impact, for papers by Sandra Merscher Breakdown of academic impact, for papers by Daniela Rottoli Breakdown of academic impact, for papers by Daniela Macconi Breakdown of academic impact, for papers by Anna Franca Milia Breakdown of academic impact, for papers by Babu J. Padanilam Breakdown of academic impact, for papers by Andrea Hartner
Rankless by CCL
2026